[1] Hsu C Y, McCulloch C E, Fan D, et al. Community-based incidence of acute renal failure[J].Kidney Int,2007,72(2):208-212. [2] Zeng X, McMahon G M, Brunelli S M, et al. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals[J]. Clin J Am Soc Nephrol, 2014, 9(1):12-20. [3] Shinjo H, Sato W, Imai E, et al. Comparison of kidney injury network criteria for assessing patients in intensive care units[J]. Clin Exp Nephrol,2014,18(5):737-745. [4] Fang Y, Ding X, Zhong Y,et al. Acute kidney injury in a Chinese hospitalized population[J].Blood Purif,2010,30(2):120-126. [5] KDIGO Acute Kidney Injury Working Group. Kidney Disease:Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury[J]. Kidney Int Suppl, 2012,2:1-138. [6] Hoste E A, Lameire N H, Vanholder R C,et al. Acute renal failure in patients with sepsis in a surgical ICU:predictive factors,incidence,comorbidity,and outcome[J].J Am See Nephrol, 2003,14:1022-1030. [7] Macedo E,Mehta R L.Renal recovery after acute kidney injury[J].Contrib Nephrol,2016,187:24-35. [8] 张丽琴,邢昌赢,解林花. 重症急性肾损伤患者经连续性肾脏替代治疗后肾功能恢复的影响因素[J].现代医学生物进展,2014,14(8):1490-1493. [9] Schiffl H, Fischer R. Five-year outcomes of severe acute kidney injury requiring renal replacement therapy[J]. Nephrol Dial Transplant,2008,23(7):2235-2241. [10] Lins R L, Elseviers M M, Daelemans R, et al. Re-evaluation and modification of the stuivenberg hospital acute renal failure (SHARF) scoring system for the prognosis of acute renal failure:an independent multicentre, prospective study[J].Nephrol Dial Transplant, 2004,19(9):2282-2288. [11] Lopes J A, Jorge S, Resina C, et al. Acute kidney injury in patients with sepsis:a contemporary analysis[J].Int J Infect Dis, 2009,13(2):176-181. [12] Abelha F J, Botelho M, Fernandes V,et al.Determinants of postoperative acute kidney injury[J].Crit Care,2009,13(3):R79. [13] Demirkiliç U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery[J].J Card Surg,2004,19(1):17-20. [14] Piccinni P, Dan M, Barbacini S, et al. Early isovolaemic haemofiltration in oliguric patients with septic shock[J].Intensive Care Med,2006,32(1):80-86. [15] Bagshaw S M, Uchino S, Bellomo R, et al. Timing of renal replacement theraphy and clinical outcomes in critically ill patients with severe acute kidney injury[J].J Crit Care,2009,24(1):129-140. [16] Oppert M, Engel C, Brunkhorst F M, et al.Acute renal failure in patients with severe sepsis and septic shock a significant independent risk factor for mortality:results from the german prevalence study[J].Nephrol Dial Transplant, 2008,23(3):904-909. [17] Chen H, Wu B, Gong D, et al. Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome:a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide measurement[J].Crit Care,2015,19:135. [18] Bagshaw S M, George C, Bellomo R. Early acute kidney injury and sepsis:a multicentre evaluation[J].Crit Care, 2008,12(2):R47. [19] Endre Z H. Recovery from acute kidney injury:the role of biomarkers[J]. Nephron Clin Pract, 2014,127(1-4):101-105. [20] Singer E, Markó L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin:Pathophysiology and clinical applications[J]. Acta Physiol, 2013,2007(4):663-672. [21] Mårtensson J, Bell M, Oldner A, et al.Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury[J]. Intensive Care Med,2010,36(8):1333-1340. [22] Srisawat N, Murugan R, Lee M, et al. Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia[J].Kidney International,2011,80(5):545-552. [23] Park S O, Ahn J Y, Lee Y H, et al. Plasma neutrophil gelatinase-associated lipocalin as an early predicting biomarker of acute kidney injury and clinical outcomes after recovery of spontaneous circulation in out-of-hospital cardiac arrest patients[J].Resuscitation, 2016,101:84-90. [24] Parr S K, Clark A J, Bian A, et al. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury[J].Kidney Int,2015,87(3):640-648. [25] Doi K, Noiri E, Maeda-Mamiya R, et al. Urinary L-type fatty acid-bindingprotein as a new biomarker of sepsis complicated with acute kidney injury[J].Crit Care Med,2010,38(10):2037-2042. [26] Hoste E A, McCullough P A, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers[J].Nephrol Dial Transplant, 2014,29(11):2054-2061. [27] Bihorac A, Chawla L S, Shaw A D, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication[J]. Am J Respir Crit Care Med, 2014,189(18):932-939. |